Gate Square “Creator Certification Incentive Program” — Recruiting Outstanding Creators!
Join now, share quality content, and compete for over $10,000 in monthly rewards.
How to Apply:
1️⃣ Open the App → Tap [Square] at the bottom → Click your [avatar] in the top right.
2️⃣ Tap [Get Certified], submit your application, and wait for approval.
Apply Now: https://www.gate.com/questionnaire/7159
Token rewards, exclusive Gate merch, and traffic exposure await you!
Details: https://www.gate.com/announcements/article/47889
Caixin discloses Chen Zhi's domestic asset details: holds a 17.78% stake in Xiamen Jueshi Wushen Interactive Technology and was once the controlling shareholder of a certain medical device company.
Deep Tide TechFlow News, on January 8th, Caixin Online disclosed the details of Chen Zhi’s assets within China. It is reported that he holds a 17.78% stake in Xiamen Jueshi Wushen Interactive Technology Co., Ltd., a company mainly engaged in mobile game development. He also holds a 70% stake in Chongqing Qusu Infinite Equity Investment Fund Management Co., Ltd., which has invested in several entertainment technology companies. Chen Zhi was also a controlling shareholder of Jiangmen Dacheng Medical Equipment Co., Ltd., a medical device company, with a shareholding ratio of over 56%.
In addition, Chen Zhi is the controlling shareholder of two listed companies in Hong Kong, and owns multiple insurance brokerage firms, securities companies, wealth management companies, and shell companies with unclear business operations. In December 2018, Chen Zhi took control of Zhihada, and after acquiring a 54.79% stake, he served as the company’s chairman and executive director until resigning from all positions in July 2025. In 2023, Chen Zhi took over all shares previously sold by the original major shareholder of Kun Group, gaining an absolute controlling stake of 55%, but he has not served as an executive director. Currently, these two listed companies have not suspended trading and issued statements stating that sanctions will not have any significant adverse impact on the group’s business operations.